세계의 소아 특발성 관절염 진단 시장 보고서(2025년)

Juvenile idiopathic arthritis (JIA) diagnosis refers to the medical procedures and tests used to detect JIA, a chronic autoimmune disorder in children that leads to persistent joint inflammation, pain, and stiffness, which can result in long-term joint damage and mobility challenges. It occurs when the immune system mistakenly attacks the body's own joint tissues due to a combination of genetic and environmental factors, causing inflammation that, if left untreated, can lead to growth problems, vision issues, and a diminished quality of life.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary methods for diagnosing juvenile idiopathic arthritis include serological tests, imaging tests, and genetic tests. Serological tests analyze blood to detect specific markers that suggest inflammation or autoimmune activity related to JIA. Key diagnostic technologies include molecular diagnostics, immunoassays, and flow cytometry. Diagnostic services, consultation services, and laboratory services are provided in settings such as hospital laboratories, diagnostic centers, and research institutions.

The juvenile idiopathic arthritis diagnostic market research report is one of a series of new reports from The Business Research Company that provides juvenile idiopathic arthritis diagnostic market statistics, including the juvenile idiopathic arthritis diagnostic industry's global market size, regional shares, competitors with a juvenile idiopathic arthritis diagnostic market share, detailed juvenile idiopathic arthritis diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the juvenile idiopathic arthritis diagnostic industry. This juvenile idiopathic arthritis diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The juvenile idiopathic arthritis diagnostic market size has grown strongly in recent years. It will grow from$4.75 billion in 2024 to $5.04 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to the rising prevalence of juvenile idiopathic arthritis, increased awareness of pediatric autoimmune disorders, early detection initiatives, greater healthcare investments, and a heightened focus on pediatric care.

The juvenile idiopathic arthritis diagnostic market size is expected to see strong growth in the next few years. It will grow to$6.32 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth during the forecast period can be attributed to growing collaborations between research institutions, rising demand for early and accurate diagnostic solutions, increasing prevalence of autoimmune and inflammatory disorders, initiatives by government and healthcare organizations, and the rise of telemedicine and digital health platforms. Key trends in the forecast period include technological advancements, improvements in diagnostic technologies, personalized treatment approaches, and innovations in diagnostic tools.

The rising prevalence of autoimmune disorders is expected to significantly drive the growth of the juvenile idiopathic arthritis (JIA) diagnostic market in the coming years. Autoimmune disorders are conditions in which the immune system erroneously attacks the body's healthy cells, causing inflammation, tissue damage, and chronic health complications. The increasing incidence of autoimmune diseases is linked to a combination of environmental triggers, genetic factors, and lifestyle changes. In the case of juvenile idiopathic arthritis, these disorders cause the immune system to target the synovial tissue in joints, leading to inflammation and potential joint damage. For instance, a report from Versorgungsatlas.de, a Germany-based interactive online platform, indicated that in 2022, among 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, representing a prevalence rate of 8.61%. Therefore, the growing incidence of autoimmune disorders is driving the demand for juvenile idiopathic arthritis diagnostics.

Leading companies in the juvenile idiopathic arthritis diagnostic market are increasingly forming strategic partnerships to expand their product offerings, enhance research capabilities, and strengthen their global market presence. These partnerships focus on advancing early detection and more accurate diagnosis. For example, in November 2024, Augurex Life Sciences Corp., a biotechnology company based in Canada, entered into a partnership with Quest Diagnostics, a US-based diagnostic services company, to improve the diagnosis and management of rheumatoid arthritis (RA) through the use of the 14-3-3η (eta) biomarker. As part of the collaboration, Quest Diagnostics will validate and offer a lab-developed test in the United States based on Augurex's 14-3-3η biomarker, which helps detect elevated levels of the 14-3-3η protein-associated with rheumatoid arthritis and a higher risk of joint damage and disease severity.

In September 2023, Globus Medical Inc., a US-based medical device company, merged with NuVasive Inc. to offer surgeons and patients a comprehensive range of musculoskeletal procedural solutions and advanced technologies. This merger aims to improve the overall continuum of care, expand the companies' global operations, and significantly enhance their portfolios in arthritis and orthopedic treatments. NuVasive, a US-based company, specializes in developing medical devices and procedures focused on orthopedic and idiopathic conditions.

Major players in the juvenile idiopathic arthritis diagnostic market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Agilent Technologies, Sartorius AG, Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter Life Sciences, DiaSorin, Miltenyi Biotec, Cytek Biosciences, BD Biosciences, Angstrom Biotech, Sony Biotechnology, Theradiag, J. Mitra, Chimera Biotech, Stratedigm, Apogee Flow Systems, and Avecon Healthcare.

North America was the largest region in the juvenile idiopathic arthritis diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in juvenile idiopathic arthritis diagnostic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the juvenile idiopathic arthritis diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The juvenile idiopathic arthritis diagnostic market consists of revenues earned by entities by providing services such as clinical evaluations, blood tests, ophthalmologic screenings, bone density scans, and synovial fluid analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The juvenile idiopathic arthritis diagnostic market also includes sales of bone density scanners, AI-based diagnostic software, imaging equipment, and biomarker-based diagnostic panels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Juvenile Idiopathic Arthritis Diagnostic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on juvenile idiopathic arthritis diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for juvenile idiopathic arthritis diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The juvenile idiopathic arthritis diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Serological Tests; Imaging Tests; Genetic Tests
• 2) By Technology: Molecular Diagnostics; Immunoassays; Flow Cytometry
• 3) By Services: Diagnostic Services; Consultation Services; Laboratory Services
• 4) By Application: Hospital Laboratories; Diagnostic Centres; Research Institutes
• Subsegments:
• 1) By Serological Tests: Rheumatoid Factor (RF) Test, Antinuclear Antibody (ANA) Test, Erythrocyte Sedimentation Rate (ESR) Test, C-Reactive Protein (CRP) Test, Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test, Complete Blood Count (CBC)
• 2) By Imaging Tests: X-Ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scan, Bone Scintigraphy (Bone Scan)
• 3) By Genetic Tests: HLA-B27 Genetic Marker Test, Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)-Based Testing
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Agilent Technologies; Sartorius AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Juvenile Idiopathic Arthritis Diagnostic Market Characteristics

3. Juvenile Idiopathic Arthritis Diagnostic Market Trends And Strategies

4. Juvenile Idiopathic Arthritis Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Juvenile Idiopathic Arthritis Diagnostic Growth Analysis And Strategic Analysis Framework

• 5.1. Global Juvenile Idiopathic Arthritis Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Juvenile Idiopathic Arthritis Diagnostic Market Growth Rate Analysis
• 5.4. Global Juvenile Idiopathic Arthritis Diagnostic Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Juvenile Idiopathic Arthritis Diagnostic Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Juvenile Idiopathic Arthritis Diagnostic Total Addressable Market (TAM)

6. Juvenile Idiopathic Arthritis Diagnostic Market Segmentation

• 6.1. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serological Tests
• Imaging Tests
• Genetic Tests
• 6.2. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry
• 6.3. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Services
• Consultation Services
• Laboratory Services
• 6.4. Global Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Laboratories
• Diagnostic Centers
• Research Institutes
• 6.5. Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Serological Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rheumatoid Factor (RF) Test
• Antinuclear Antibody (ANA) Test
• Erythrocyte Sedimentation Rate (ESR) Test
• C-Reactive Protein (CRP) Test
• Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test
• Complete Blood Count (CBC)
• 6.6. Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• X-Ray
• Magnetic Resonance Imaging (MRI)
• Ultrasound
• Computed Tomography (CT) Scan
• Bone Scintigraphy (Bone Scan)
• 6.7. Global Juvenile Idiopathic Arthritis Diagnostic Market, Sub-Segmentation Of Genetic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• HLA-B27 Genetic Marker Test
• Whole Exome Sequencing (WES)
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)-Based Testing

7. Juvenile Idiopathic Arthritis Diagnostic Market Regional And Country Analysis

• 7.1. Global Juvenile Idiopathic Arthritis Diagnostic Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Juvenile Idiopathic Arthritis Diagnostic Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market

• 8.1. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Juvenile Idiopathic Arthritis Diagnostic Market

• 9.1. China Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 9.2. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Juvenile Idiopathic Arthritis Diagnostic Market

• 10.1. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Juvenile Idiopathic Arthritis Diagnostic Market

• 11.1. Japan Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 11.2. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Juvenile Idiopathic Arthritis Diagnostic Market

• 12.1. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market

• 13.1. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Juvenile Idiopathic Arthritis Diagnostic Market

• 14.1. South Korea Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 14.2. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market

• 15.1. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 15.2. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Juvenile Idiopathic Arthritis Diagnostic Market

• 16.1. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Juvenile Idiopathic Arthritis Diagnostic Market

• 17.1. Germany Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Juvenile Idiopathic Arthritis Diagnostic Market

• 18.1. France Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Juvenile Idiopathic Arthritis Diagnostic Market

• 19.1. Italy Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Juvenile Idiopathic Arthritis Diagnostic Market

• 20.1. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market

• 21.1. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 21.2. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Juvenile Idiopathic Arthritis Diagnostic Market

• 22.1. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Juvenile Idiopathic Arthritis Diagnostic Market

• 23.1. North America Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 23.2. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Juvenile Idiopathic Arthritis Diagnostic Market

• 24.1. USA Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 24.2. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Juvenile Idiopathic Arthritis Diagnostic Market

• 25.1. Canada Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 25.2. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Juvenile Idiopathic Arthritis Diagnostic Market

• 26.1. South America Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 26.2. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Juvenile Idiopathic Arthritis Diagnostic Market

• 27.1. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Juvenile Idiopathic Arthritis Diagnostic Market

• 28.1. Middle East Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 28.2. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Juvenile Idiopathic Arthritis Diagnostic Market

• 29.1. Africa Juvenile Idiopathic Arthritis Diagnostic Market Overview
• 29.2. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Juvenile Idiopathic Arthritis Diagnostic Market, Segmentation By Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Juvenile Idiopathic Arthritis Diagnostic Market Competitive Landscape And Company Profiles

• 30.1. Juvenile Idiopathic Arthritis Diagnostic Market Competitive Landscape
• 30.2. Juvenile Idiopathic Arthritis Diagnostic Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sartorius AG Overview, Products and Services, Strategy and Financial Analysis

31. Juvenile Idiopathic Arthritis Diagnostic Market Other Major And Innovative Companies

• 31.1. Sysmex Corporation
• 31.2. Bio-Rad Laboratories
• 31.3. Beckman Coulter Life Sciences
• 31.4. DiaSorin
• 31.5. Miltenyi Biotec
• 31.6. Cytek Biosciences
• 31.7. BD Biosciences
• 31.8. Angstrom Biotech
• 31.9. Sony Biotechnology
• 31.10. Theradiag
• 31.11. J. Mitra
• 31.12. Chimera Biotech
• 31.13. Stratedigm
• 31.14. Apogee Flow Systems
• 31.15. Avecon Healthcare

32. Global Juvenile Idiopathic Arthritis Diagnostic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Juvenile Idiopathic Arthritis Diagnostic Market

34. Recent Developments In The Juvenile Idiopathic Arthritis Diagnostic Market

35. Juvenile Idiopathic Arthritis Diagnostic Market High Potential Countries, Segments and Strategies

• 35.1 Juvenile Idiopathic Arthritis Diagnostic Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Juvenile Idiopathic Arthritis Diagnostic Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Juvenile Idiopathic Arthritis Diagnostic Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34884_Juvenile_Idiopathic_Arthritis_Diagnostic_GMR_2025